Connect with us

Technology

Chandigarh University’s Biotechnology & Pharmacy Students Secure 178 Placements with Leading Pharmaceutical and Biotechnology Companies

Published

on

Leading national & global companies like Sun Pharma, GSK, Medtronic India, Serum Institute of India recruit Chandigarh University students

CHANDIGARH, India, July 30, 2026 /PRNewswire/ — The rapid growth of Biotechnology, Pharmaceutical Sciences and allied healthcare fields has triggered a high demand for professionals equipped with specialized knowledge, practical skills and industry exposure. To meet this growing demand, Chandigarh University has integrated experiential learning model into its Biotechnology and Pharmaceutical Sciences programmes with 178 students securing placements and 261 students gaining industry internships in leading pharmaceutical companies, reputed healthcare institutions (hospitals) and life sciences organisations over the past three years.

The University Institute of Biotechnology (UIBT) and University Institute of Pharmaceutical Sciences (UIPS) jointly attracted more than 97 national and multinational companies, healthcare institutions and life sciences organizations including Sun Pharma, GlaxoSmithKline (GSK), Mankind Pharma, Medtronic India, Macleods Pharmaceuticals, Centrient Pharmaceuticals, Serum Institute of India, Bharat Serum and Vaccine Limited, IDS Infotech and Ind-Swift Limited, among others.

Chandigarh University students have also extended their professional footprint beyond India, building careers in the leading international healthcare and pharmaceutical companies in different parts of the world.

Among all premiere companies, IDS Infotech has emerged as the largest recruiter for biotechnology students of CU with eight placement offers while Ind-Swift Limited provided the highest number of job opportunities in the Pharmacy department recruiting 11 students from Chandigarh University.

The University Institute of Biotechnology emerged as the largest contributor to the combined placement performance with 118 students securing placements and 252 students completing internships over the past three years. As many as 65 companies participated in the department’s recruitment process during this period, with 2024-25 emerging as the strongest placement year, when 54 students secured job offers in leading national and international companies.

The students secured job offers from IDS Infotech, Cryoviva Biotech Pvt. Ltd., Bharat Serum and Vaccine Limited, Fitelo India Pvt. Ltd., Mikky Publication Services Pvt. Ltd., Serum Institute of India, Integrated Resources and Macleod Pharmaceutical Ltd among other leading companies. Among these IDS Infotech offered the highest number of job offers which was eight whereas Cryoviva Biotech, Bharat Serum and Vaccine Limited, Fitelo India and Mikky Publication Services offered six job offers each.

At the programme level, MSc Biotechnology recorded the highest number of selections with 59 students securing placements over the three-year period. This was followed by B.Sc. Biotechnology with 27 placements, M.Sc. Industrial Microbiology with 15, M.Sc. Microbiology with 10 and B.Sc. Microbiology with six placements.

The students of Biotechnology and Microbiology secured placements with leading pharmaceutical, biotechnology and healthcare organisations with several graduates receiving attractive salary packages. The highest annual package of ₹8 lakh was secured by students of M.Sc. Biotechnology and M.Sc. Industrial Microbiology in 2023–24 while an M.Sc. Microbiology student secured an annual salary package of ₹7.5 lakh from Wellcove (CGCS Services Inc.) in 2025–26.

The students from University Institute of Pharmaceutical Sciences secured 60 placements and nine industry internships over the past three years.

As many as five students also secured internships with Sun Pharma, one of India’s leading pharmaceutical companies, providing them with valuable industry exposure. The students from the Pharmaceutical Sciences department have secured job placements in top brands such as Ind-Swift Limited, GlaxoSmithKline (GSK), Mankind Pharma, Medtronic India, Macleods Pharmaceuticals, Centrient Pharmaceuticals, ADI Group, Nectar Lifesciences, Psychocare Health and Evalueserve among other leading organisations.

Ind-Swift Limited emerged as the largest recruiter by selecting the highest number of students which was 11. Endo India Par Formulations and Macleods Pharmaceuticals selected five students each while Proelio Technologies and Psychocare Health selected four students each. GlaxoSmithKline (GSK) also recruited three students, while Medtronic India, Mankind Pharma and Centrient Pharmaceuticals provided career opportunities to students from the department.

The department’s placement performance has also been reflected in strong salary packages across programmes. Gehna, a Pharm.D student, secured the highest salary package of ₹9.6 LPA at Karuna Cancer Hospital. Similarly, Ayush Sneh, Atul Chaubey and Armaan, B. Pharmacy students were selected by GlaxoSmithKline (GSK) as Medical Representatives at annual salary packages of ₹7.5 lakh each.

Mandvi Pandey, an M. Pharmacy student, secured a ₹7 lakh annual package as Junior Analyst at Evalueserve. Several students have also secured Quality Assurance and Quality Control roles at Ind-Swift Limited, while others have obtained opportunities in Quality Control and internship-based roles with Macleods Pharmaceuticals and Centrient Pharmaceuticals. Sneha Kumari is working as a Pharmacopoeial Associate at the Indian Pharmacopoeia Commission, Ghaziabad, under the Ministry of Health and Family Welfare, Government of India. Another student of Chandigarh University, Hasan Zubair is serving as Head of the Pharmaceutical Policy Division at the Ministry of Health, Zanzibar, Tanzania. Navpreet Bhullar is working as a Pharmacy Assistant within the healthcare system in Alberta, Canada.

These job placements reflect the diverse career opportunities available to Chandigarh University graduates, with students (graduates) contributing not only to leading private pharmaceutical and healthcare companies but also to national and international public health systems.

The strong placement achievements by students from Chandigarh University are supported by a robust culture of research and innovation. Over the past three years, students have published more than 40 research papers in reputed international journals and publications. Two design patents have been granted, while three patents have been filed. Several students have also qualified CSIR-NET JRF and secured admission to PhD programmes at premier institutions including the Indian Institute of Science (IISc), Bengaluru, IIT Delhi, IIT Roorkee and IIIM Jammu.

The department’s students have also achieved international academic success. Tanish Bhalla was selected for the Erasmus Mundus Joint Master’s Degree in Leading International Vaccinology Education (2024–26). Yashika Hablani secured an opportunity for higher education at the University of Melbourne, Australia, while Vamshi Kadari is working as a Graduate Research Assistant at California State University, Fresno, USA. Ishana Goyal secured admission to the M.Sc. Biotechnology programme at the University of Rome Tor Vergata, Italy.

The entrepreneurial achievements of students have further strengthened Chandigarh University’s reputation as a hub for innovation and entrepreneurship. Vedant Rinwa founded Nutripanda Life Care LLP, while Deepanshi established Nubody&CO. The students have also founded startups including Algazen & Okiss Pvt. Ltd., creating new avenues for innovation and entrepreneurship in the life sciences sector.

About Chandigarh University

Chandigarh University is a NAAC A+ Grade University and QS World Ranked University. This autonomous educational institution is approved by UGC and is located near Chandigarh in the state of Punjab. It is the youngest university in India and the only private university in Punjab to be honoured with A+ Grade by NAAC (National Assessment and Accreditation Council). CU offers more than 109 UG and PG programs in the field of engineering, management, pharmacy, law, architecture, journalism, animation, hotel management, commerce, and others. It has been awarded as The University with Best Placements by WCRC.

Website address: https://www.cuchd.in/

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/chandigarh-universitys-biotechnology–pharmacy-students-secure-178-placements-with-leading-pharmaceutical-and-biotechnology-companies-302839047.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Dreame to Launch X60 Ultra Extreme in Singapore on 1 September 2026

Published

on

By

Extreme Reach, Extreme Precision. The Flagship Upgrade to the X60 Series, led by its industry-leading Dual Ultra Extend Arms for deeper edge and corner cleaning.

SINGAPORE, Aug. 11, 2026 /PRNewswire/ — Dreame will officially launch the Dreame X60 Ultra Extreme in Singapore on 1 September 2026, following an Early Bird campaign beginning on 17 August 2026.

Built around the campaign theme “Extreme Reach, Extreme Precision,” X60 Ultra Extreme is Dreame’s latest flagship robot vacuum, designed to clean beyond open floor areas and reach further into corners, furniture recesses and spaces beneath cabinets.

Its key innovation is Dreame’s industry-leading Dual Ultra Extend Arm Technology, a dual joint system that allows both the side brush and mop pad to extend and adjust their angles according to the surrounding space. The SideReach side brush extends by up to 12cm, while the MopExtend system reaches up to 18cm diagonally, helping to reduce areas that would otherwise require manual follow-up cleaning.

Dreame is the world’s first brand to launch a robot vacuum featuring dual bionic extending robotic arms, including multi-stage extending bionic robotic arms. For years, fixed-form robot vacuums have been constrained by physical limits, leaving corners and edges uncleaned. Our extendable arm technology breaks this barrier, expanding cleaning coverage and delivering truly seamless autonomous cleaning.

More adaptive whole-home cleaning

The X60 Ultra Extreme combines its extended cleaning reach with Dreame’s upgraded AI-Enhanced OmniSight System, featuring dual 120° wide-angle AI cameras, lateral 3D structured light and LED illumination. Together, these technologies enable more responsive navigation, precise obstacle avoidance and intelligent whole-home cleaning.

Its Proactive Illumination Dirt Detection system is designed to identify fine particles, hair and lighter-coloured liquids, then adjust the robot’s cleaning strategy according to the type of mess detected. For dry debris, the robot can increase suction and lift its mop pads. For liquid messes, the brushes lift while the mop pads lower, helping to reduce the risk of wet debris entering the dust box or being spread across the floor.

Delivering up to 42,000Pa Vormax suction, the X60 Ultra Extreme offers industry-leading cleaning power to collect dust, hair and larger household debris across hard floors and carpets. It also features the upgraded HyperStream Detangling DuoBrush 2.0, designed to collect debris effectively while reducing hair entanglement.

For mopping, its Dual Omni-Scrub mop pads rotate at up to 280RPM and apply up to 15N (Imagine a 1.5kg bag of rice) of downward pressure to tackle more stubborn stains. VersaLift Navigation also retracts the robot’s sensor when entering low-clearance areas, allowing it to clean beneath suitable beds, sofas and cabinets while maintaining intelligent navigation.

The upgraded ProLeap Obstacle Crossing System enables the robot to clear eligible single layer obstacles of up to 5.2cm and double-layer obstacles of up to 10cm, subject to specified obstacle dimensions.

Automated maintenance through the PowerDock

After cleaning, the X60 Ultra Extreme returns to its all-in-one PowerDock for automated maintenance.

The PowerDock features Dreame’s industry-first 100°C ThermoHub Mop Self-Cleaning system, which heats the washboard surface to temperatures of up to 100°C under Dreame laboratory conditions, helping to loosen grease and residue from the mop pads. The dock then dries the mop pads with hot air.

It also supports automatic dust emptying for up to 100 days under Dreame’s testing conditions, water refilling, cleaning solution dispensing and washboard cleaning. An optional water hookup kit can support automatic water refilling and drainage. “The next step in robot cleaning is not simply greater suction power, but the ability to reach and respond more effectively to the spaces around the home,” said Mr Jacky Zhong, General Manager of Dreame Southeast Asia. “The X60 Ultra Extreme combines industry-leading reach, intelligent dirt detection and automated maintenance to reduce the need for manual follow-up cleaning.”

Singapore Availability

The Dreame X60 Ultra Extreme Early Bird campaign will begin on 17 August 2026, ahead of its official Singapore launch on 1 September 2026. Interested customers can experience live in-store demonstrations at the following locations:

Online: www.dreame.sgRetail: Dreame Official Stores, COURTS Heeren (Orchard) and COURTS Megastore (Tampines)

About Dreame Technology

Established in 2017, Dreame Technology is a trailblazer in smart home appliances that enhance lives through cutting-edge technology. The official distributor for Dreame Technology in Singapore is DM Dasher Pte Ltd. Stay updated by following us on Facebook, Instagram, and TikTok, or visit https://dreame.sg.

Industry-leading and industry-first claims are based on Dreame’s internal research and product comparisons available as of the product’s release date. All stated performance figures are based on Dreame in-house laboratory testing. Actual performance may vary depending on the home environment, floor type, selected settings and usage conditions. The 10cm obstacle crossing figure applies to eligible double-layer obstacles under specified dimensional requirements. Up to 100 days of automatic dust emptying is based on Dreame laboratory calculations. Optional accessories are subject to local availability and installation compatibility.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/dreame-to-launch-x60-ultra-extreme-in-singapore-on-1-september-2026-302848025.html

SOURCE Dreame Technology

Continue Reading

Technology

Canara HSBC Life Insurance Launches ‘The Viral Parivar’, a Digital-First Micro-Drama Series Bringing Financial Preparedness into Everyday Conversations

Published

on

By

The humorous digital micro-drama series highlights why financial preparedness is essential in a rapidly changing world

NEW DELHI, Aug. 11, 2026 /PRNewswire/ — Canara HSBC Life Insurance Company Limited (“Canara HSBC Life Insurance”) has launched The Viral Parivar, a digital micro-drama series that captures the everyday realities of India’s middle-class families as they navigate the opportunities and uncertainties of an increasingly digital-first world. Through relatable humour, family-centric storytelling and socially relevant themes, the campaign explores concerns around social media influence, digital scams, impact of AI on jobs and evolving financial priorities of modern Indian families.

As part of its broader marketing approach, Canara HSBC Life Insurance is leveraging content formats and platforms that resonate with today’s consumers. Recognising the popularity of short-form video content, the brand is using storytelling-led digital content to encourage conversations around financial wellness and preparedness in a way that feels relevant and accessible. Short-form formats such as Reels enable the brand to engage audiences through everyday stories and cultural moments that naturally lend themselves to sharing and discussion.

The Viral Parivar is anchored on platforms such as Instagram and YouTube shorts, which have become important spaces for self-expression, community engagement and cultural conversations. For younger, digitally native audiences, content often resonates most when it reflects their everyday experiences, aspirations and challenges. Through relatable characters, familiar situations and bite-sized narratives, the series seeks to make conversations around financial protection and long-term planning more relevant and relatable.

Through this initiative, Canara HSBC Life Insurance continues to strengthen its commitment to helping customers safeguard their financial future and fulfil the promises they make to their loved ones. The campaign reflects the company’s philosophy of being a ‘Promises Ka Partner’, empowering families with the confidence that comes from long-term financial protection in an ever-changing world.

The campaign is now live across Canara HSBC Life Insurance’s Instagram, Facebook and YouTube channels.

Instagram: https://www.instagram.com/reel/DbvSqIVvWE-/?igsh=MWZleHNrMGkwcTlldA%3D%3D Facebook: https://www.facebook.com/share/v/19KjvHNBN8/YouTube: AI vs Human | The Viral Parivar Episode 1 | Canara HSBC Life Insurance

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/canara-hsbc-life-insurance-launches-the-viral-parivar-a-digital-first-micro-drama-series-bringing-financial-preparedness-into-everyday-conversations-302848056.html

Continue Reading

Technology

INTURAI EXPANDS CRITICAL INFRASTRUCTURE SECURITY CAPABILITIES THROUGH PROPOSED DOMECOMMAND ACQUISITION AS GLOBAL COUNTER-UAS FOCUS INTENSIFIES

Published

on

By

(CSE: URAI / OTC: URAIF / FSE: 3QG0)
 investor@inturai.com

Highlights

German authorities are investigating an explosives-laden drone discovered at Leipzig/Halle Airport, one of Europe’s largest cargo and logistics hubs, an incident that officials have described in publicly reported statements as a “new quality of danger” to critical infrastructure. Inturai was not involved in the incident; the Company believes such events underscore the growing need for advanced drone response capabilities across airports, logistics hubs and critical infrastructure.

The Company’s proposed acquisition of DomeCommand, announced July 6, 2026, expands Inturai’s capabilities in counter-UAS command-and-control: a deterministic solver designed to compute optimized engagement plans, AI reasoning agents that provide explainable judgement, and an evidence-linked audit trail behind every decision.

The Company is engaged in a 12-week proof-of-capability program for DomeCommand with the European Defence Tech Hub, targeting initial milestones in the fourth quarter of 2026. The global counter-UAS market is forecast to grow from US$9.17 billion in 2026 to US$29.70 billion by 2031, a 26.5% compound annual growth rate.*

The Company has simulated how DomeCommand would defend against drone attacks if involved in the recent explosives-equipped drone event at Leipzig/Halle Airport.

WATCH VIDEO

WATCH VIDEO – German Subtitles

VANCOUVER, BC, Aug. 11, 2026 /PRNewswire/ — Inturai Ventures Corp. (the “Company”) (CSE: URAI) (OTC: URAIF) (FSE: 3QG0) is pleased to provide an update on DomeCommand, the counter-UAS command-and-control platform the Company has agreed to acquire announced July 6th, 2026, as governments, airports and critical infrastructure operators reassess their drone response.

German authorities are investigating an explosives-equipped drone discovered at Leipzig/Halle Airport, one of Europe’s largest cargo and logistics hubs. The discovery temporarily disrupted airport operations and triggered a national security investigation. In publicly reported statements (Reuters, August 2026), German officials described the incident as a “new quality of danger” for critical infrastructure. Inturai was not involved in the incident and has no connection to it, and no party involved in the incident has evaluated, endorsed or engaged the Company or DomeCommand.

The Company believes such events underscore a structural feature of the counter-UAS challenge: threat detection and threat response are distinct capabilities. In the Company’s assessment, much of the operational gap now sits in the response-coordination layer, where sensor data must be fused, engagements planned and assets directed. That is the layer DomeCommand addresses, while much of the sector’s current activity focuses on detection hardware, effectors, and drone services. The global counter-UAS market is forecast to grow from US$9.17 billion in 2026 to US$29.70 billion by 2031, a 26.5% compound annual growth rate.*

Ed Clarke, CEO of Inturai Ventures Corp., commented: “The counter-UAS challenge has shifted from seeing threats to acting on them in seconds. DomeCommand was built for that decision layer: a solver that computes the response, reasoning agents that explain it, and an audit trail that stands behind every action. All of it is designed to run on a single workstation an operator can field, and our focus for the next twelve months is disciplined execution of our proof-of-capability program in Europe.”

DomeCommand pairs a deterministic solver, designed to compute engagement plans optimized against defined constraints, with AI reasoning agents that provide explainable judgement. Every decision is recorded in an evidence-linked audit trail. To the Company’s knowledge, based on its review of publicly available information, no other commercially available platform combines both approaches. The platform is designed to fuse radar, radio-frequency, electro-optical/infrared, acoustic and air-traffic sensor data into a single operating picture, and to coordinate drones, ground robots, personnel and effectors through open protocols including MAVLink and Cursor-on-Target/ATAK.

DomeCommand is designed to run offline on a single workstation. The Company believes this hardware-light architecture could enable cost-constrained operators, including regional airports, logistics hubs and utilities, to field decision-layer capability without cloud dependency or a large-scale procurement program. Cost-aware engagement planning is designed to match the response to the threat, tasking low-cost effectors against low-cost drones rather than committing high-value interceptors.

The Company is engaged in a 12-week program with the European Defence Tech Hub, targeting milestones in the fourth quarter of 2026. It is also collaborating in Asia, including with the Republic of Singapore Air Force; the Company is yet to enter into formal agreements in respect of those discussions.

The proposed DomeCommand acquisition remains subject to customary closing conditions and has not yet closed. Upon closing, it would establish defence and critical-infrastructure autonomy as a lead vertical for the Company, complementing its existing spatial intelligence platform. Inturai intends to integrate DomeCommand into its technology platform while pursuing commercial opportunities across government, industrial, and enterprise markets.

On behalf of the Board of Directors

About Inturai Ventures

Inturai Ventures is advancing intelligent environments with cutting-edge AI technologies, transforming industries such as healthcare, military, smart homes, and industrial applications.

For more information, visit www.inturai.com.

For investor inquiries:

On behalf of the Board of Directors

Ed Clarke, CEO
Inturai Ventures Corp.
Email: investor@inturai.com
Phone: (+1) 604 339-0339

This document contains certain forward-looking statements that are based on assumptions as of the date of this news release. Forward-looking statements are frequently characterized by words such as “anticipates”, “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, “positioned” and other similar words, or statements that certain events or conditions “may” or “will” occur. All such forward-looking statements involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company’s control. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/inturai-expands-critical-infrastructure-security-capabilities-through-proposed-domecommand-acquisition-as-global-counter-uas-focus-intensifies-302847777.html

SOURCE INTURAI VENTURES CORP.

Continue Reading

Trending